Vol. 8 (02) pp. 887-892 DOI: 10.21474/IJAR01/10522

AN ANALYSIS OF PAP AND PAP - HPV TESTING FOR CERVICAL CANCER SCREENING IN TERTIARY CARE CENTER A RETROSPECTIVE STUDY IN A TEACHING INSTITUITION OF GOVT. MADURAI MEDICAL COLLEGE HOSPITAL, MADURAI, TAMIL NADU

and
  • Assistant Professor, Department of Pathology, Govt Villupuram Medical College, Mundiyampakkam, Villupuram.
  • Associate Professor, Department of Pathology, Madurai Medical College.
20 Downloads 118 Views
Crossref

Download Full Paper (PDF)

Abstract

Background: To prevent cancer cervix, cervical cancer screening is one of the emerging health programme in all primary as well as tertiary care institution. In 2012, updated cervical cancer screening recommendation was released with consensus on Pappnicolaou ( PAP ) testing every 3 years for women aged 21 ? 65 years ( or ) PAP ? Humen Pailloma Virus ( HPV) co testing at 5 ? year intervals for women aged 30 ? 65 years. Materials and Methods: This prospective study was done at the tertiary care hospital from January 2017 to December 2017. 51 women were selected for screening HPV. The laboratory results were reported according to the new Bethesda system for reporting cervical cytology 2014. Results: Out of 51 cases, 17 HPV positive cases showed high risk genotype. Commonest high risk genotype detected was HPV 16 followed by HPV 35. And also 11 cases showed HPV positivity even with normal Pap smear study. Conclusion: HPV Testing along with pap smear are mandatory since there is high detection rate of HPV even in those with normal Pap smear.

Keywords

Article Analytics

References

  1. Bobdey S, Sathwara J, Jain A, Balasubramaniam G. Burden of cervical cancer and role of screening in India. Indian J Med Paediatr Oncol 2016;37:278-85.
  2. Ansari M, Mehdi G, Arif SH, Ansari H, Khan T. Smear patterns and spectrum of premalignant and malignant cervical epithelial lesions in postmenopausal Indian women: A hospital based study. Diagn Cytopathol 2012;40:976 -83.
  3. Bal MS, Goyal R, Suri AK, Mohi MK. Detection of abnormal cervical cytology in papanicolaou smears. J Cytol 2012;29:45-47.
  4. Sachan PL, Singh M, Patel ML, Sachan R. A study on cervical cancer screening using pap smear test and clinical correlation. Asia Pac J Oncol Nurs 2018;5:337-41.
  5. Patel MM, Pandya AN, Modi J. Cervical pap smear study and its utility in cancer screening, to specify the strategy for cervical cancer control. Natl J Community Med 2011;2:49-51.
  6. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012;62:147-72.
  7. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer.J Clin Pathol 2002;55:244-265.
  8. Dallenback G.Hellweg, Knebel M.V Doeberitz, Trunk M.J. Colour Atlas of Histopathology of the cervix uterine, 2nd ed, 2006; Germany, Springer.Pg 83-84
  9. Crum CP, Egawa K, Levine RU et al (1983) Human papillomavirus infection (condyloma) of
  10. the cervix and cervical intraepithelial neoplasia: a histological and statistical analysis. Gynecol Oncol 15:88
  11. de Villiers EM, Fauquet C, Broker TR et al (2004) Classification of papillomaviruses. Virology 324(1):17?27
  12. zur Hausen H (2009) The search for infectious causes of human cancers: where and why (Nobel lecture). Angewandte Chemie 48(32):5798?5808
  13. Gia ? Khanh Nguyen , Brendra Smith.Essentials of Gynecologic cytology .2011; Spring ,Canada. Pg 78-85
  14. Solomon D, Nayar R, eds. The Bethesda System for Reporting Cervical Cytology. Definitions, Criteria, and Explanatory Notes. 2nd ed. New York, NY: Springer-Verlag; 2004.
  15. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy. J Natl Cancer Inst 2005;97:888?95.
  16. Molijn A, Kleter B, Quint W, van Doorn LJ. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 2005;32:S43?S51.

How to Cite This Article

S. Suganya and G. Jeyanthi (2020); AN ANALYSIS OF PAP AND PAP - HPV TESTING FOR CERVICAL CANCER SCREENING IN TERTIARY CARE CENTER A RETROSPECTIVE STUDY IN A TEACHING INSTITUITION OF GOVT. MADURAI MEDICAL COLLEGE HOSPITAL, MADURAI, TAMIL NADU, Int. J. of Adv. Res., 8 (02), 887-892, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/10522

Corresponding Author

DR.G.JEYANTHI.
DEPARTMENT OF PATHOLOGY ,MADURAI MEDICAL COLLEGE
Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.